ROVI PHARMA TECHNOLOGY RDI

Projektträger – zwischengeschaltetes Finanzinstitut

LABORATORIOS FARMACEUTICOS ROVI SA

Ort

• Spanien

Beschreibung

The project concerns the promoter's research, development and innovation (RDI) activities for various drug-delivery technologies, including preclinical development and clinical studies.

Ziele

ROVI's pharmacological investigations involved in the project strengthen ROVI's innovativeness and help the company to maintain its competitive edge and expand its international footprint.

Sektor(en)

• Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 45 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 94 million

Umweltaspekte

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation, as appropriate.

Auftragsvergabe

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation.

Projektstatus

Unterzeichnet - 21/12/2017